News & Events

Old drug may have new tricks for fighting cancer

February 4, 2018

In recent years, a powerful suite of drugs known as kinase inhibitors have been developed to treat cancer and other diseases. Primary targets of such drugs include a family of receptor tyrosine kinases (RTKs) which protrude from cell surfaces like antennae and can activate cancer-related pathways in virtually all types of cancer when signaling molecules bind with them. In a new study, researchers at Arizona State University’s Biodesign Institute used an innovative method to screen a broad...

ASU research project to tackle a nuclear emergency moves to product development phase

January 17, 2018

Editor's note: The following article is an excerpt from a Genomeweb news feature When a false alarm warning of an impending nuclear missile launch recently panicked Hawaiians, it raised bigger questions on U.S. emergency preparedness. ASU has been at the research forefront with a multi-million, multi-year project aimed at helping to triage a population in the event of a nuclear emergency. Recently, GenomeWeb updated its readers on the progress of Project Bioshield, funded by the...

ASU launches inaugural Lab Safety Innovation Award

January 11, 2018

The Laboratory Safety Committee will issue awards for safe research practices After receiving his doctorate in microbiology in the 1980s, Mitch Magee, now a researcher in the Biodesign Institute at Arizona State University, began studying tuberculosis (TB) in a lab on the East Coast. Because TB is a highly infectious, airborne disease, the lab purchased a centrifuge tool with a special lid to keep the bacteria from getting in the air. “We were smart. We knew what we were...

Evolution and Cancer take center stage at ISEEC conference

January 8, 2018

  Evolution is the creative force shaping all earthly life. It is also the reason why all multicellular life is susceptible to cancer. The processes of evolution are the fuel behind the interplay of malignant cells with the bodies they attack. From Dec 7-10th, researchers attended ISEEC 2017, the conference of the International Society for Evolution, Ecology and Cancer, held on the Tempe campus of Arizona State University. The conference, which is held every other year, drew a highly...

Chinese partners bring strong potential to advance research at Biodesign Institute

January 3, 2018

ASU’s approach toward global research engagement addresses some of the most pressing problems facing us in health today—including global pandemics and a growing cancer incidence in the developing world—that are tied to issues that require multiple, transnational partners to come up with solutions more rapidly. Recently, ASU Biodesign Institute Executive Director Joshua LaBaer led a delegation to visit key Chinese partners to further explore new research possibilities. The stops...

Mayo Clinic, ASU collaborate to seed and accelerate research

December 18, 2017

In Silicon Valley, investors flock to back potentially disruptive new technology and apps — even if they are still in development. But the funding landscape is a little different for health research. Although novel ideas have great potential to radically improve health care and medicine, funding agencies usually choose to fund well-established research. This can be a barrier for researchers with new ideas. Together, Arizona State University and Mayo Clinic are addressing this challenge and...

Sugar-coated world

December 18, 2017

Sugar-coated world Glycans are essential to virtually every biological process in the body. These complex structures—composed of interlocking sugar molecules—adorn the surfaces of cells in fuzzy profusion. Glycans are a crucial part of a cell’s identity, helping it communicate with other cells and with the external environment. Glycans are also known to play a vital role in cancer, autoimmune disease and countless other afflictions. Despite their ubiquity and importance, glycans...

Liquid Biopsy, Opportunity and Challenges in Practice

November 8, 2017

Presented by Jianyu Rao, M.D., Professor, University of California Los Angeles, Ronald Reagan Medical Center. There are high expectations that liquid biopsy, including analysis of circulating tumor cells, circulating tumor DNA and exosomes may bring disruptive changes in the diagnosis and management of variety diseases, especially cancer. In this presentation, Rao will discuss the potential applications and challenges of liquid biopsy in cancer diagnosis and management. 

Diagnostic revolution targets tuberculosis, other deadly diseases

November 1, 2017

Skeletal remains dating to the Neolithic era in Egypt bear tell-tale traces of tuberculosis (TB)—a disease that is estimated to have killed a billion people in the last two centuries alone. The bacteria responsible for TB can lurk in a person’s lung tissue for decades before producing active, infectious TB disease and it is estimated that a third of the global population may have such dormant infections, with 5 percent to 10 percent progressing to active disease. Detecting TB is...

ASU team turns smartphone into a powerful microscope in the fight against infectious diseases

October 26, 2017

With smartphones millions of times more powerful than the NASA Apollo computers that sent us to the moon in the 1960s, scientists have been eager to adapt them back here on Earth to better the planet. That’s exactly what ASU Biodesign Institute researcher Tony Hu and postdoctoral researcher Dali Sun have recently demonstrated in the fight against infectious diseases. They’ve developed a simple mobile technology for clinics, hospitals and health organizations that are on the front...